Scholarlink

<p>People with Down syndrome (DS) develop Alzheimer’s disease (AD) neuropathology by the age of 40 years, with cognitive decline common after age 50. While amyloid precursor protein overexpression due to trisomy 21 is a major driver of AD pathology, increasing evidence indicates that DS-related white matter aging involves broader mechanisms beyond amyloid. This review synthesizes neuropathological, neuroimaging, molecular, and fluid biomarker studies linking white matter pathology to cognition in DS.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

White matter aging across the lifespan in Down syndrome: developmental origins, Alzheimer's disease progression, and therapeutic implications

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月26日

查看全文
  • Justine A. Silva,
  • Jr-Jiun Liou,
  • Simren Parikh,
  • Natalie C. Edwards,
  • Julia Kofler,
  • Milos D. Ikonomovic,
  • Florence Lai,
  • H. Diana Rosas,
  • David K. Powell,
  • Frederick A. Schmitt,
  • Patrick J. Lao,
  • Donna M. Wilcock,
  • Adam M. Brickman,
  • Elizabeth Head

摘要

People with Down syndrome (DS) develop Alzheimer’s disease (AD) neuropathology by the age of 40 years, with cognitive decline common after age 50. While amyloid precursor protein overexpression due to trisomy 21 is a major driver of AD pathology, increasing evidence indicates that DS-related white matter aging involves broader mechanisms beyond amyloid. This review synthesizes neuropathological, neuroimaging, molecular, and fluid biomarker studies linking white matter pathology to cognition in DS.